Filter
2933
Filtered Results: 2933
Text search:
Drug
Resistance
Featured
Recommendations
308
New Publications
743
Language
Document type
No document type
1612
Studies & Reports
459
Guidelines
456
Manuals
138
Strategic & Response Plan
107
Fact sheets
59
Training Material
48
Situation Updates
15
Infographics
15
Resource Platforms
9
Brochures
5
Online Courses
5
Videos
3
App
2
Countries / Regions
India
157
Global
103
South Africa
81
Kenya
79
Western and Central Europe
75
Ethiopia
61
Uganda
53
Tanzania
51
Africa
49
Nepal
48
Eastern Europe
47
Zambia
42
Nigeria
40
Latin America and the Carribbean
40
Liberia
37
Sierra Leone
34
Malawi
32
Namibia
32
Ghana
31
Philippines
31
Myanmar / Burma
31
Bangladesh
29
Asia
28
Rwanda
27
Cambodia
24
Lesotho
22
South–East Asia Region
22
Zimbabwe
20
Ukraine
19
Senegal
19
Russia
19
Indonesia
19
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
Venezuela
10
Thailand
9
Syria
9
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Haiti
7
Germany
7
East and Southern Africa
7
Argentina
7
Vietnam
7
Pakistan
7
Tajikistan
6
China
6
Laos
6
Benin
5
Guinea
5
USA
5
Western Pacific Region
5
Georgia
5
El Salvador
4
Iran
4
Peru
4
Brazil
4
Sri Lanka
4
Sudan
4
Iraq
4
North Macedonia
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
North America
3
Uruguay
3
Lebanon
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Somalia
3
Switzerland
2
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Libya
2
Ecuador
2
Madagascar
2
Guatemala
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Romania
1
Greece
1
Angola
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1038
Clinical Guidelines
296
Public Health
129
Women & Child Health
83
Key Resources
74
Capacity Building
46
Pharmacy & Technologies
41
Annual Report MEDBOX
1
Toolboxes
TB
511
HIV
354
AMR
329
NTDs
122
Mental Health
114
Malaria
112
COVID-19
96
Pharmacy
74
Caregiver
50
Planetary Health
48
Rapid Response
40
NCDs
37
Ebola & Marburg
33
Global Health Education
33
Refugee
31
2.0 Rapid Response
24
Health Financing Toolbox
23
Polio
17
Conflict
14
Cholera
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
It is essential that all people, including people living with HIV, are able to access health services and ongoing treatment. If people living with HIV who are on ART stop abruptly because they cannot access new supplies they could rapidly become unwell, drug resistance may build and the chances of o...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
Each year, WHO’s World malaria report provides a comprehensive and up-to-date assessment of trends in malaria control and elimination across the globe. This year’s report includes, for the first time, a dedicated chapter focused on the intersection between climate change and malaria. As describe...
Malaria remains a significant public health concern, particularly in sub-Saharan Africa, where the majority of cases and fatalities occur, especially among children under five. Although there was a significant decline in global mortality and incidence between 2000 and 2015, progress has stalled sinc...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Antimicrobial resistance (AMR) occurs when disease-causing pathogens are able to withstand the killing or suppressing power of antimicrobial medicines. This phenomenon increases the global burden of infectious diseases and strains health systems.This course aims to improve the learner's awareness an...
This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for drug-resistant tuberculosis (DR-TB).
WHO commissioned a survey, carried out in September/October 2015, among some 10 000 members of the public in 12 countries (2 per WHO Region: Barbados, China, Egypt, India, Indonesia, Mexico, Nigeria, the Russian Federation, Serbia, South Africa, Sudan and Viet Nam) on their use of antibiotics, knowl...
Frequently asked questions on Antimicrobial resistance.
